Claret Asset Management’s Repligen RGEN Stock Holding History

Claret Asset Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Sell	1,647 -206	-11%	-$25.3K	0.02%	395
2026 Q1	$218K	Hold	1,853	–	–	0.03%	314
2025 Q4	$304K	Sell	1,853 -4	-0.2%	-$627	0.04%	176
2025 Q3	$248K	Sell	1,857 -26	-1%	-$3.16K	0.03%	259
2025 Q2	$234K	Buy	1,883 +311	+20%	+$39.6K	0.03%	286
2025 Q1	$200K	Buy	1,572 +1	+0.1%	+$154	0.03%	284
2024 Q4	$226K	Buy	1,571 +11	+0.7%	+$1.58K	0.04%	232
2024 Q3	$232K	Buy	+1,560	New	+$224K	0.04%	206
2021 Q4	–	Sell	-732	Closed	-$212K	–	193
2021 Q3	$212K	Buy	+732	New	+$188K	0.04%	159

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Claret Asset Management's RGEN Position: Q2 2026 in Review

Claret Asset Management reduced its Repligen (RGEN) stake by 11% in Q2 2026, selling an estimated $25.3K and leaving 1,647 shares worth $225K. The position accounts for 0.02% of the portfolio, ranked #395.

Claret Asset Management first reported a position in RGEN in Q3 2021 and has held it in 9 quarters since. The position peaked at $304K in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Claret Asset Management held 1,647 shares of Repligen worth $225K as of Q2 2026.
Claret Asset Management sold 206 Repligen shares in Q2 2026, an estimated $25.3K.
Repligen made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #395 holding.
Claret Asset Management first reported a position in Repligen in Q3 2021 and has held it in 9 quarters since.
Claret Asset Management's Repligen position peaked at $304K in Q4 2025.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.